A global view of hepatocellular carcinoma: trends, risk, prevention and management

JD Yang, P Hainaut, GJ Gores, A Amadou… - Nature reviews …, 2019 - nature.com
Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death
worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol …

[HTML][HTML] 2018 Korean Liver Cancer Association–National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

Korean Liver Cancer Association - Korean Journal of Radiology, 2019 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline

S Apisarnthanarax, A Barry, M Cao, B Czito… - Practical radiation …, 2022 - Elsevier
Purpose This guideline provides evidence-based recommendations for the indications and
technique-dose of external beam radiation therapy (EBRT) in hepatocellular carcinoma …

Treatment and the prognosis of hepatocellular carcinoma in Asia

T Torimura, H Iwamoto - Liver International, 2022 - Wiley Online Library
Hepatocellular carcinoma is the most common type of malignant tumour in Asia. Treatment
is decided according to the staging system with information on tumour burden and liver …

[HTML][HTML] Locoregional therapy approaches for hepatocellular carcinoma: recent advances and management strategies

MS Makary, U Khandpur, JM Cloyd, K Mumtaz… - Cancers, 2020 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and third
leading cause of cancer-related mortality worldwide. While surgical resection and …

[HTML][HTML] History and evolution of yttrium-90 radioembolization for hepatocellular carcinoma

A Saini, A Wallace, S Alzubaidi, MG Knuttinen… - Journal of clinical …, 2019 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and
affects millions worldwide. Due to the lack of effective systemic therapies for HCC …

[HTML][HTML] Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions

R Inchingolo, A Posa, M Mariappan… - World journal of …, 2019 - ncbi.nlm.nih.gov
Liver cancers are the second most frequent cause of global cancer-related mortality of which
90% are attributable to hepatocellular carcinoma (HCC). Despite the advent of screening …

2018 Korean Liver Cancer Association-National Cancer Center Korea practice guidelines for the management of hepatocellular carcinoma

JW Park, JS Lee, KS Suh, JW Chung, J Seong… - Gut and …, 2019 - scholarworks.bwise.kr
Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

[HTML][HTML] Recent advances in locoregional therapy of hepatocellular carcinoma

A Podlasek, M Abdulla, D Broering, K Bzeizi - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is the fifth most common cancer
worldwide and the second most common oncological reason for death. Liver resection and …

[HTML][HTML] Hepatocellular carcinoma: surveillance, diagnosis, evaluation and management

J Elderkin, N Al Hallak, AS Azmi, H Aoun, J Critchfield… - Cancers, 2023 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is the most common primary liver cancer.
High-risk patients should undergo semi-annual surveillance. Management of HCC is …